Beigene Foundation News Today

Armenia and Nepal are the first of 29 countries to receive BRUKINSA ...

The Max Foundation Max a global nonprofit organization dedicated to accelerating health equity by delivering medication technology and supportive services to patients worldwide BeiGene a global oncology company and the BeiGene Foundation have been administered for the treatment of adult patients with chronic lymphocytic leukemia CLL to patients in Armenia and Nepal as part of a threeyear collaboration to provide access to the medicine in 29 low and middleincome countries LMICs.

BASEL, Switzerland, BEIJING, & CAMBRIDGE, Mass., August 02, 2023--BeiGene, Ltd. (NASDAQ: BGNE; HKEX: 06160; SSE: 688235), a global biotechnology company, today reported financial results from the second quarter of 2023 and business highlights.

The Max Foundation (Max), a global nonprofit organization dedicated to accelerating health equity by delivering medication, technology, and supportive services to patients worldwide, BeiGene, a global

The Max Foundation , a global nonprofit organization dedicated to accelerating health equity by delivering medication, technology, and supportive services to patients worldwide, BeiGene, a global... | May 17, 2023